Phosphorylation by Akt disables the anti-oncogenic activity of YB-1

A G Bader1, P K Vogt

  • 1Department of Molecular & Experimental Medicine, The Scripps Research Institute, La Jolla, CA 78744, USA.

Oncogene
|August 21, 2007
PubMed

Insights

Phosphorylation by Akt disables the inhibitory activity of Y-box binding protein 1 (YB-1), enhancing oncogenic translation. Overexpressing wild-type YB-1 overrides this inactivation, maintaining protein synthesis inhibition and resistance to transformation.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Oncogenesis

Background:

  • Y-box binding protein 1 (YB-1) is a DNA/RNA-binding protein regulating mRNA translation.
  • YB-1 inhibits protein synthesis at higher concentrations and confers resistance to oncogenic transformation.
  • YB-1 is a direct substrate of Akt, but the functional significance of its phosphorylation is unknown.

Purpose of the Study:

  • To investigate the functional significance of Akt-mediated YB-1 phosphorylation in PI3K-induced transformation.
  • To explore the effect of phosphorylated YB-1 on cellular transformation by generating YB-1 mutants.

Main Methods:

  • Generated YB-1 mutants in the Akt phosphorylation consensus sequence.
  • Assessed the effect of wild-type and mutant YB-1 on PI3K-induced transformation in chicken embryo fibroblasts.
  • Analyzed YB-1's affinity for mRNA caps and its effect on cap-dependent translation.

Main Results:

  • The phosphomimetic YB-1 S99E mutant did not interfere with cellular transformation, unlike wild-type YB-1.
  • The S99E mutant showed reduced affinity for mRNA caps and failed to inhibit cap-dependent translation.
  • Phosphorylation by Akt appears to disable YB-1's inhibitory activity, promoting oncogenic translation.

Conclusions:

  • Akt-mediated phosphorylation inactivates YB-1's translational inhibitory function, thereby promoting oncogenesis.
  • Overexpression of wild-type YB-1 can overcome Akt-mediated inactivation, preserving protein synthesis inhibition and transformation resistance.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...